Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global HIV Drugs Market
5.1 Market Performance
5.2 Market Breakup by Drug Class
5.3 Market Breakup by Distribution Channel
5.4 Market Breakup by Region
5.5 Market Forecast

6 North America HIV Drugs Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast

7 North America HIV Drugs Market: Breakup by Drug Class
7.1 Nucleoside Reverse Transcriptase Inhibitors
7.2 Multi-Class Combination Products
7.3 Protease Inhibitors
7.4 HIV Integrase Strand Transfer Inhibitors
7.5 Non-Nucleoside Reverse Transcriptase Inhibitors
7.6 Entry Inhibitors ? CCR5 Co-Receptor Antagonist
7.7 Others

8 North America HIV Drugs Market: Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.2 Retail Pharmacies
8.3 Online Pharmacies
8.4 Others

9 North America HIV Drugs Market: Breakup by Country
9.1 United States
9.1.1 Historical Market Trends
9.1.2 Market Breakup by Drug Class
9.1.3 Market Breakup by Distribution Channel
9.1.4 Market Forecast
9.2 Canada
9.2.1 Historical Market Trends
9.2.2 Market Breakup by Drug Class
9.2.3 Market Breakup by Distribution Channel
9.2.4 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis
11.1 Overview
11.2 Research and Development
11.3 Raw Material Procurement
11.4 Manufacturing
11.5 Marketing
11.6 Distribution
11.7 End-Use

12 Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players

List of Figures

Figure 1: North America: HIV Drugs Market: Major Drivers and Challenges
Figure 2: Global: HIV Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: HIV Drugs Market: Breakup by Drug Class (in %), 2021
Figure 4: Global: HIV Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 5: Global: HIV Drugs Market: Breakup by Region (in %), 2021
Figure 6: Global: HIV Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 7: North America: HIV Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 8: North America: HIV Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: North America: HIV Drugs Market: Breakup by Drug Class (in %), 2021
Figure 10: North America: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: North America: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: North America: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: North America: HIV Drugs (Multi-Class Combination Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: North America: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: North America: HIV Drugs (Protease Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: North America: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: North America: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: North America: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: North America: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: North America: HIV Drugs (Entry Inhibitors ? CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: North America: HIV Drugs (Entry Inhibitors ? CCR5 Co-Receptor Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: HIV Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: HIV Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: HIV Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 25: North America: HIV Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2016 & 2021
Figure 26: North America: HIV Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2022-2027
Figure 27: North America: HIV Drugs Market: Sales through Retail Pharmacies (in Million US$), 2016 & 2021
Figure 28: North America: HIV Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2022-2027
Figure 29: North America: HIV Drugs Market: Sales through Online Pharmacies (in Million US$), 2016 & 2021
Figure 30: North America: HIV Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2022-2027
Figure 31: North America: HIV Drugs Market: Sales through Other Distribution Channels (in Million US$), 2016 & 2021
Figure 32: North America: HIV Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2022-2027
Figure 33: North America: HIV Drugs Market: Breakup by Country (in %), 2021
Figure 34: United States: HIV Drugs Market: Sales Value (in Million US$), 2016-2021
Figure 35: United States: HIV Drugs Market: Breakup by Drug Class (in %), 2021
Figure 36: United States: HIV Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 37: United States: HIV Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Canada: HIV Drugs Market: Sales Value (in Million US$), 2016-2021
Figure 39: Canada: HIV Drugs Market: Breakup by Drug Class (in %), 2021
Figure 40: Canada: HIV Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 41: Canada: HIV Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: North America: HIV Drugs Industry: SWOT Analysis
Figure 43: North America: HIV Drugs Industry: Value Chain Analysis
Figure 44: North America: HIV Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: HIV Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: North America: HIV Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: North America: HIV Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: North America: HIV Drugs Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 5: North America: HIV Drugs Market: Competitive Structure
Table 6: North America: HIV Drugs Market: Key Players